The Effect of Probiotics on Functional Constipation in the Elderly

Status Completed

Clinical Trial Summary

The main scope of the proposed research in the framework is to investigate the effect of probiotic bacteria Lactobacillus acidophilus LA3, Bifidobacterium animalis ssp. lactis BLC1 i Lactobacillus casei BGP93 on functional constipation and on the quality of life of the elderly in a nursing home. The experimental part will consists of double-blind, placebo-controlled clinical trial over 12 weeks.

Clinical Trial Description

During the first four weeks, the subjects were monitored primarily concerning bowel discharges and general health. After that initial four weeks, they are re-evaluated compliance with inclusion and exclusion criteria. Participants were allocated to the double-blind section of the trial (12 weeks), using o computer-generated to a placebo group or in the probiotic group in the form of a liquid oral formulation once a day. On first day of intervention participants provide a blood sample. All investigators, participants and study personnel were blinded to the order of randomization. Participants were told to consume 9 drops of study probiotics once a day for next 12-week intervention. On last day of intervention, participants provide a blood sample. The last four weeks of the double-blind section (week 9-12) participants an evaluation period in which the respondents were evaluated for the outcomes of the study. After completing the double-blind study, the participants were followed for an additional four weeks. Inclusive / Excluded criteria are evaluated on two occasions, at the time of inclusion in the 4-week introductory section and its end. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04506801
Study type	Interventional
Source	University of Zagreb
Contact
Status	Completed
Phase	N/A
Start date	September 25, 2018
Completion date	May 25, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04620161` - A Proof of Concept Study of Pradigastat in Patients With Functional Constipation	Phase 2
Active, not recruiting	`NCT02361749` - Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation	Phase 4
Completed	`NCT03054805` - The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation	Phase 4
Not yet recruiting	`NCT01913665` - The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation	N/A
Completed	`NCT01622972` - Mode of Action of Moviprep	Phase 4
Completed	`NCT01348152` - Effect of TU-100 in Patients With Functional Constipation	Phase 2
Completed	`NCT01212146` - Probiotic-enriched Artichoke in Functional Constipation	N/A
Completed	`NCT04231162` - Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation	N/A
Not yet recruiting	`NCT03639142` - Dried Plums (Prunes) vs. Polyethylene Glycol 4000 for Treatment of Functional Constipation in Children	Phase 3
Recruiting	`NCT04918329` - Functional Digestive Disorders Observatory
Completed	`NCT02592200` - Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women	N/A
Completed	`NCT03707002` - Effect of scFOS on Increase in Stool Frequency in Constipated People	N/A
Recruiting	`NCT06083311` - The Efficacy of a Probiotic for Functional Constipation (FC)	N/A
Completed	`NCT04110145` - Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation	Phase 2
Recruiting	`NCT06196073` - Visceral Osteopathy in Functional Constipation	N/A
Completed	`NCT04026113` - Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)	Phase 3
Completed	`NCT02359396` - A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics	Phase 1
Completed	`NCT01847950` - Effects of scFOS on Stool Frequency in People With Functionnal Constipation	N/A
Recruiting	`NCT01274793` - Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy	Phase 1
Active, not recruiting	`NCT04166058` - Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C	Phase 3